141 results
8-K
EX-10.1
CYCC
Cyclacel Pharmaceuticals Inc
2 May 24
Cyclacel Pharmaceuticals ANNOUNCES $8.0 MILLION PRIVATE PLACEMENT
5:00pm
in any “derivative” transaction. The Company further understands and acknowledges that (y) one or more Purchasers may engage in hedging activities … Shares deliverable with respect to Securities are being determined, and (z) such hedging activities (if any) could reduce the value of the existing
8-K
EX-10.2
CYCC
Cyclacel Pharmaceuticals Inc
2 May 24
Cyclacel Pharmaceuticals ANNOUNCES $8.0 MILLION PRIVATE PLACEMENT
5:00pm
a specified number of such securities at a stipulated price per security;
through the writing or settlement of options or other hedging transactions … , the Selling Stockholders may enter into hedging transactions with broker-dealers or other financial institutions, which may in turn engage in short sales
424B3
q5v8a67nr7h
14 Feb 24
Prospectus supplement
4:06pm
8-K
EX-10.2
jtecdg yafnz
26 Dec 23
Cyclacel Pharmaceuticals Announces Registered Direct and Private Placement Offering Priced At-The-Market Under Nasdaq Rules
9:29am